You have 9 free searches left this month | for more free features.

PDE5 inhibitors

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

ive Alzheimer's Medicines - PDE5 Inhibitors vs Endothelin

Active, not recruiting
  • Pulmonary Arterial Hypertension
  • PDE5 inhibitor
  • Endothelin Receptor Antagonists
  • Boston, Massachusetts
    Brigham and Women's Hospital
Nov 15, 2021

Erectile Dysfunction Following Radiation Therapy, Phosphodiesterase Inhibitor Adverse Reaction, Platelet- Rich Plasma (PRP)

Active, not recruiting
  • Erectile Dysfunction Following Radiation Therapy
  • +2 more
  • P shot arm ( Autologous Platelet Rich Plasma)
  • PDE5i arm
  • Mansoura, Outside U.S./Canada, Egypt
    Mansoura urology and nephrology center
Mar 15, 2023

Erectile Dysfunction Trial in Banha (OnabotulinumtoxinA, Trimix)

Recruiting
  • Erectile Dysfunction
  • Banha, Kalubiaya, Egypt
    Banha University Hospitals
Jan 6, 2022

Erectile Dysfunction Trial in Saint Petersburg (PDE5 inhibitor (tadalafil) and BTL-6000 fSWT, PDE5 inhibitor (tadalafil))

Recruiting
  • Erectile Dysfunction
  • PDE5 inhibitor (tadalafil) and BTL-6000 fSWT
  • PDE5 inhibitor (tadalafil)
  • Saint Petersburg, Russian Federation
    SBPSU
Apr 10, 2023

Cystic Fibrosis Trial in Denver, Augusta (Sildenafil 40mg oral capsule, Placebo Oral capsule)

Recruiting
  • Cystic Fibrosis
  • Sildenafil 40mg oral capsule
  • Placebo Oral capsule
  • Denver, Colorado
  • +1 more
Aug 29, 2022

Behçet's Disease Trial in Beijing (Hemay005, Placebo)

Recruiting
  • Behçet's Disease
  • Beijing, Beijing, China
    Peking University People's Hospital
Nov 17, 2023

Healthy, Obese Trial in Nashville (Tadalafil, Placebo)

Completed
  • Healthy
  • Obese
  • Nashville, Tennessee
    Vanderbilt University Medical Center
May 3, 2022

Obesity Trial in Nashville (Tadalafil 20 MG, Placebo)

Recruiting
  • Obesity
  • Tadalafil 20 MG
  • Placebo
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Mar 29, 2022

Benign Prostatic Hyperplasia Trial (Phosphodiesterase 5 Inhibitors, Alpha Blockers, Combined Alpha Blockers and

Not yet recruiting
  • Benign Prostatic Hyperplasia
  • Phosphodiesterase 5 Inhibitors
  • +2 more
  • (no location specified)
Feb 10, 2022

Carotid Artery Intima Media Thickness Can Predict Response to

Completed
  • Erectile Dysfunction Due to Arterial Disease
  • CIMT (Carotid artery intima media thickness measurement)
  • Bursa, Turkey
    Bursa Yuksek Ihtisas Training and Research Hospital
Jan 11, 2023

Pharmacologic Interaction Between ERAs and PDE-5 Inhibitors on

Completed
  • Pulmonary Arterial Hypertension
  • no intervention, only observation of different groups
  • Heidelberg, Germany
    Centre for pulmonary hypertension, Thoraxclinic at the Universit
Jan 24, 2020

Pulmonary Hypertension, COPD Trial (Tadalafil)

Not yet recruiting
  • Pulmonary Hypertension
  • Chronic Obstructive Pulmonary Disease
  • (no location specified)
Apr 25, 2023

Single-ventricle, Pulmonary Hypertension, Univentricular Heart Trial (Sildenafil, Placebos)

Not yet recruiting
  • Single-ventricle
  • +2 more
  • (no location specified)
Jan 20, 2022

Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in

Recruiting
  • Malignant Pleural Mesothelioma, Advanced
  • Oncolytic Adenovirus H101
  • Programmed death receptor-1 inhibitor
  • Tianjin, Tianjin, China
    Tianjin Medical Unversity Second Hospital
Sep 2, 2023

Skin Health and Quality of Life in Patients Receiving

Not yet recruiting
  • Lung Cancer
  • +7 more
  • EQ-5D-5L questionnaire
  • +2 more
  • Roma, Italy
    Roberto Iacovelli
May 17, 2023

Learn About Use and Effects of CDK4/6 Inhibitors in Canadian

Active, not recruiting
  • Breast Cancer
    • Kirkland, Quebec, Canada
      Pfizer Canada
    Mar 5, 2023

    Underlying Conditions in Men Prescribed a PDE5 Inhibitor

    Completed
    • Erectile Dysfunction
    • +2 more
    • no intervention
    • (no location specified)
    Jul 15, 2021

    Renal Transplant Failure Trial in Vancouver (Sildenafil)

    Not yet recruiting
    • Renal Transplant Failure
    • Vancouver, British Columbia, Canada
      Vancouver General Hospital
    Nov 3, 2020

    Pulmonary Arterial Hypertension Trial in Worldwide (Riociguat (Adempas, BAY63-2521), Sildenafil, Tadalafil)

    Completed
    • Pulmonary Arterial Hypertension
    • Riociguat (Adempas, BAY63-2521)
    • +2 more
    • Phoenix, Arizona
    • +80 more
    Feb 3, 2021

    Retinitis Pigmentosa Trial in Nantes (AAV2/5-hPDE6B)

    Active, not recruiting
    • Retinitis Pigmentosa
    • AAV2/5-hPDE6B
    • Nantes, France
      Clinique Ophtalmologique, CHU de Nantes
    Feb 28, 2022

    Diabete Type 2 Trial in El Sadat (Sitagliptin 50 mg, Empagliflozin 12.5 MG, Sitagliptin 50 mg + Empagliflozin 12.5 MG)

    Completed
    • Diabete Type 2
    • Sitagliptin 50 mg
    • +3 more
    • El Sadat, Egypt
      University of Sadat City
    Apr 27, 2022

    Generalized Myasthenia Gravis Trial (zilucoplan (RA101495))

    Not yet recruiting
    • Generalized Myasthenia Gravis
    • zilucoplan (RA101495)
    • (no location specified)
    Aug 22, 2022

    Premature Ejaculation Trial (Sildenafil 50 mg, Placebo, Tramadol Hydrochloride 100 MG)

    Not yet recruiting
    • Premature Ejaculation
    • Sildenafil 50 mg
    • +2 more
    • (no location specified)
    Dec 21, 2021

    PCO Trial in Bani Suwayf (Dapagliflozin 5 MG, Metformin Hydrochloride 1000 MG, Dapagliflozin/Metformin)

    Recruiting
    • PCO
    • Dapagliflozin 5 MG
    • +2 more
    • Banī Suwayf, Beni Suef, Egypt
      Beni-suef university
    Oct 26, 2022

    Rectal Cancer Trial (Sildenafil, Placebo)

    Not yet recruiting
    • Rectal Cancer
    • (no location specified)
    Nov 3, 2023